Drew Moghanaki, Professor, Chief of Thoracic Oncology at the Department of Radiation Oncology and Stanley Iezman and Nancy Stark Endowed Chair in Thoracic Radiation Oncology Research at David Geffen School of Medicine at UCLA, and Chief Medical Officer of Respirati, shared a post on X:
“I agree with Erin A Gillaspie that patients with unresectable tumors should not be sent down a neoadjuvant pathway at this time.
I also believe the legal risks are real and tough to defend in a court of law if a patient’s family chooses to sue a medical center for recommending such an approach.”
More posts featuring Drew Moghanaki.